Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma

Published:2005 Issue:1 Volume:8 Page:90-99
ISSN:1099-498X
Container-title:The Journal of Gene Medicine
language:en
Short-container-title:J. Gene Med.

Author:

Nakano Hiroshi,Kishida Tsunao,Asada Hidetsugu,Shin-Ya Masaharu,Shinomiya Takashi,Imanishi Jiro,Shimada Taketoshi,Nakai Shigeru,Takeuchi Minoru,Hisa Yasuo,Mazda Osam

Publisher

Wiley

Subject

Genetics(clinical),Drug Discovery,Genetics,Molecular Biology,Molecular Medicine

Reference39 articles.

1. . Tumor immunity and immuno-gene therapy of malignancies. In Frontiers in Immuno-Gene Therapy, (ed). Research Signpost: Trivandrum, 2004; 1-30.

2. Cytokine Therapy for Cancer

3. Interleukin-12 in anti-tumor immunity and immunotherapy

4. Cancer Immunotherapy: A Treatment for the Masses

5. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural killer cells: a future star for immunotherapy of head and neck squamous cell carcinoma;Frontiers in Immunology;2024-08-21

2. Therapeutic potential of interleukin-21 in cancer;Frontiers in Immunology;2024-04-04

3. Interleukin-21 as an adjuvant in cancer immunotherapy: Current advances and future directions;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03

4. Biological effects of IL-21 on immune cells and its potential for cancer treatment;International Immunopharmacology;2024-01

5. An effective therapeutic regime for treatment of glioma using oncolytic vaccinia virus expressing IL-21 in combination with immune checkpoint inhibition;Molecular Therapy - Oncolytics;2022-09